Jiangsu Aidea Pharmaceutical (688488): Deeply cultivating the HIV treatment field, the sales of the Enoxome tablet, which has been included in medical insurance, have entered into a phase of volume.

The compound preparation Enotemit was successfully included in the medical insurance list, and it is expected to see a surge in sales. The scale of HIV/AIDS patients in China continues to expand, and there is still a considerable demand for long-term medication. The Chinese market for anti-HIV drugs is mainly dominated by domestically produced generic drugs.

天風證券Jun 7 12:46

Express News | The biological product sector rose underwater, with Wantai Biological Pharmacy Enterprise surging nearly 4%, followed by Junshi Bio, Zhixiang Jintai, Kainos Technologies, Jiangsu Aidea Pharmaceutical, Remegen, Changchun High-Tech Industries and others.

BreakingsJun 4 09:54

Express News | Jiangsu Aidea Pharmaceutical: plans to sign agreements related to daily operation.

BreakingsJun 3 18:04

Express News | Jiangsu Aidea Pharmaceutical's subsidiary, Enowelin Active Pharmaceutical Ingredient, has been approved for listing.

BreakingsJun 3 18:02

First coverage report of Eddy Pharmaceuticals (688488): The HIV drug market continues to expand and the innovative drug Enomitide is expected to be further released

The HIV drug market continues to expand, and the innovative drug Enomitide is expected to expand further. The company is an innovative pharmaceutical company integrating drug research and development, production and sales. It focuses on building anti-AIDS around the anti-HIV anti-virus field and the human protein field.

開源證券May 24 00:00

Eddy Pharmaceutical (688488) Company Brief Review Report: Sales of innovative drugs continue to improve and enter a stage of rapid growth

Incident: The company released its 2023 annual report. In 2023, it achieved operating income of 411 million yuan (+68.44%), net profit to mother of -76.07 million yuan, and net profit after deducting non-return to mother of -88.06 million yuan. 202

首創證券May 14 00:00